SkinBioTherapeutics (5KW) Financial Statements
SkinBioTherapeutics Financial Overview
SkinBioTherapeutics's market cap is currently $16.30M. The company's EPS TTM is $-0.00; its P/E ratio is -29.17; SkinBioTherapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.64M | $ 1.21M | $ 132.06K | $ 74.76K | $ 0.00 |
| Gross Profit | $ 2.71M | $ 683.04K | $ 85.19K | $ 45.34K | $ -5.05K |
| Operating Income | $ -826.79K | $ -2.90M | $ -3.00M | $ -2.98M | $ -1.49M |
| EBITDA | $ -196.54K | $ -2.72M | $ -2.96M | $ -2.95M | $ -1.49M |
| Net Income | $ -696.25K | $ -2.88M | $ -2.84M | $ -2.79M | $ -1.43M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.78M | $ 800.90K | $ 1.31M | $ 1.80M | $ 4.61M |
| Total Assets | $ 12.13M | $ 5.22M | $ 2.59M | $ 3.08M | $ 5.73M |
| Total Debt | $ 993.47K | $ 818.74K | $ 100.65K | $ 127.86K | $ 139.85K |
| Net Debt | $ -3.79M | $ 17.84K | $ -1.21M | $ -1.68M | $ -4.47M |
| Total Liabilities | $ 2.71M | $ 2.25M | $ 599.34K | $ 609.61K | $ 519.67K |
| Stockholders' Equity | $ 9.42M | $ 2.97M | $ 1.99M | $ 2.48M | $ 5.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.30M | $ -2.92M | $ -2.81M | $ -2.77M | $ -1.67M |
| Operating Cash Flow | $ -1.30M | $ -2.73M | $ -2.65M | $ -2.67M | $ -1.56M |
| Investing Cash Flow | $ -1.62M | $ -2.30M | $ -165.28K | $ -96.81K | $ -112.31K |
| Financing Cash Flow | $ 6.90M | $ 4.51M | $ 2.32M | $ -35.12K | $ 4.12M |
Currency in GBP
